Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gram

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1991
Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogenH H Seydewitz, J Gram, H D Bruhn, et al.
American Journal of Obstetrics and Gynecology|February 13, 1999
Effects of hormone replacement therapy on hemostatic cardiovascular risk factorsL F Andersen, J Gram, S O Skouby, et al.
Journal of Internal Medicine|February 26, 2000
Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control studyJ Gram, E M Bladbjerg, L Møller, et al.
Coronary Artery Disease|April 1, 1993
Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activatorJ Gram, S Munkvad, F W Leebeek, et al.
Thrombosis and Haemostasis|November 15, 1993
Multicentre evaluation of commercial kit methods: plasminogen activator inhibitor activityJ Gram, P J Declerck, J Sidelmann, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 26, 2000
Premenopausal smoking and bone density in 2015 perimenopausal womenA P Hermann, C Brot, J Gram, et al.
Thrombosis and Haemostasis|November 15, 1993
Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1)P J Declerck, H Moreau, J Jespersen, et al.
Coronary Artery Disease|May 1, 1997
Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarctionO D Pedersen, J Gram, X Jeunemaitre, et al.
Thrombosis Research|August 15, 1985
Plasma histidine-rich glycoprotein and plasminogen in patients with liver diseaseJ Gram, J Jespersen, S Ingeberg, et al.
Clinical Endocrinology|September 1, 1994
Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over studyT B Hansen, J Gram, P Bjerre, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1991
Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogenH H Seydewitz, J Gram, H D Bruhn, et al.
American Journal of Obstetrics and Gynecology|February 13, 1999
Effects of hormone replacement therapy on hemostatic cardiovascular risk factorsL F Andersen, J Gram, S O Skouby, et al.
Journal of Internal Medicine|February 26, 2000
Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control studyJ Gram, E M Bladbjerg, L Møller, et al.
Coronary Artery Disease|April 1, 1993
Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activatorJ Gram, S Munkvad, F W Leebeek, et al.
Thrombosis and Haemostasis|November 15, 1993
Multicentre evaluation of commercial kit methods: plasminogen activator inhibitor activityJ Gram, P J Declerck, J Sidelmann, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 26, 2000
Premenopausal smoking and bone density in 2015 perimenopausal womenA P Hermann, C Brot, J Gram, et al.
Thrombosis and Haemostasis|November 15, 1993
Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1)P J Declerck, H Moreau, J Jespersen, et al.
Coronary Artery Disease|May 1, 1997
Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarctionO D Pedersen, J Gram, X Jeunemaitre, et al.
Thrombosis Research|August 15, 1985
Plasma histidine-rich glycoprotein and plasminogen in patients with liver diseaseJ Gram, J Jespersen, S Ingeberg, et al.
Clinical Endocrinology|September 1, 1994
Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over studyT B Hansen, J Gram, P Bjerre, et al.
Pageof 15